Tocqueville Asset Management L.P. Catalyst Pharmaceuticals, Inc. Transaction History

Tocqueville Asset Management L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $82,804 - $129,586	-15,594 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.21 - $7.45 $229 - $327	-44 Reduced 0.28%	15,594 $106,000
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $158 - $223	-37 Reduced 0.24%	15,638 $90,000
Q1 2021 May 17, 2021	BUY	$3.45 - $4.69 $54,078 - $73,515	15,675 New	15,675 $72,000

325

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.25B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on Tocqueville Asset Management L.P. with notifications on news.